ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TMDX TransMedics Group Inc

127.99
3.55 (2.85%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,577,191
Bid Price 127.85
Ask Price 129.50
News -
Day High 129.66

Low
36.4201

52 Week Range

High
129.66

Day Low 123.9182
Company Name Stock Ticker Symbol Market Type
TransMedics Group Inc TMDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
3.55 2.85% 127.99 19:49:35
Open Price Low Price High Price Close Price Prev Close
125.00 123.9182 129.66 127.99 124.44
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
24,039 1,577,191 $ 127.01 $ 200,324,312 - 36.4201 - 129.66
Last Trade Time Type Quantity Stock Price Currency
19:58:49 1 $ 127.82 USD

TransMedics (TMDX) Options Flow Summary

Overall Flow

Bullish

Net Premium

764k

Calls / Puts

360.00%

Buys / Sells

120.00%

OTM / ITM

43.75%

Sweeps Ratio

0.04%

TransMedics Group Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.19B 32.72M - 241.62M -25.03M -0.77 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

TransMedics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TMDX Message Board. Create One! See More Posts on TMDX Message Board See More Message Board Posts

Historical TMDX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week90.00129.6689.99111.151,891,90637.9942.21%
1 Month76.90129.6676.9099.221,093,66051.0966.44%
3 Months89.98129.6669.4388.39899,23638.0142.24%
6 Months40.73129.6640.0179.58783,44787.26214.24%
1 Year74.11129.6636.420173.30739,89853.8872.70%
3 Years28.81129.6610.0059.41469,08399.18344.26%
5 Years22.10129.6610.0050.44381,601105.89479.14%

TransMedics Description

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes the technology to replicate near-physiologic conditions for donor organs outside of the human body.

Your Recent History

Delayed Upgrade Clock